Advertisement

Biomedical Engineering Letters

, Volume 9, Issue 4, pp 507–508 | Cite as

Electrochemical skin conductance is sensitive and has clinical utility in patients with untreated or poorly controlled diabetes

  • Marie-Laure NévoretEmail author
Letter to the Editor
  • 33 Downloads

Notes

Funding

None.

Compliance with ethical standards

Conflict of interest

M-L Névoret is a paid consultant and past employee of Impeto Medical, the developer of the Sudoscan device.

Ethical approval

All procedures performed in studies involving human participants mentioned in this Letter to the Editor were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

References

  1. 1.
    Kim S, Cho J, Ku B, Jun M, Kim G, Yoo H, Park S, Kim JU. Variability of electrochemical skin conductance for screening diabetes mellitus. Biomed Eng Lett. 2019;9(2):267–74.CrossRefGoogle Scholar
  2. 2.
    Bordier L, Dolz M, Monteiro L, Névoret M-L, Calvet J-H, Bauduceau B. Accuracy of a rapid and non-invasive method for the assessment of small fiber neuropathy based on measurement of electrochemical skin conductances. Front Endocrinol (Lausanne). 2016;7:18.CrossRefGoogle Scholar
  3. 3.
    Khalfallah K, Ayoub H, Calvet JH, Neveu X, Brunswick P, Griveau S, Lair V, Cassir M, Bedioui F. Non invasive galvanic skin sensor for early diagnosis of sudomotor dysfunction: applica-on to diabetes. IEEE Sens J. 2010;12(3):456–63.CrossRefGoogle Scholar
  4. 4.
    Vinik AI, Smith AG, Singleton JR, Callaghan B, Freedman BI, Tuomilehto J, Bordier L, Bauduceau B, Roche F. Normative values for electrochemical skin conductances and impact of ethnicity on quantitative assessment of sudomotor function. Diabetes Technol Ther. 2016;18(6):391–8.CrossRefGoogle Scholar
  5. 5.
    Obici L, Kuks JB, Buades J, Adams D, Suhr OB, Coelho T, Kyriakides T, European Network for TTR-FAP (ATTReuNET). Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr Opin Neurol. 2016;29(Suppl 1):S27–35.CrossRefGoogle Scholar
  6. 6.
    Casellini CM, Parson HK, Richardson MS, Nevoret ML, Vinik AI. Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol Ther. 2013;15(11):948–53.CrossRefGoogle Scholar
  7. 7.
    Casellini CM, Parson HK, Hodges K, Edwards JF, Lieb DC, Wohlgemuth SD, Vinik AI. Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes. PLoS ONE. 2016;11(5):e0154211.CrossRefGoogle Scholar
  8. 8.
    Selvarajah D, Cash T, Davies J, Sankar A, Rao G, Grieg M, Pallai S, Gandhi R, Wilkinson ID, Tesfaye S. SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy. PLoS ONE. 2015;10(10):e0138224.CrossRefGoogle Scholar

Copyright information

© Korean Society of Medical and Biological Engineering 2019

Authors and Affiliations

  1. 1.Impeto Medical SASParisFrance

Personalised recommendations